中科院《国际期刊预警名单（试行）》名单
2023年01月发布的2023版：不在预警名单中
2021年12月发布的2021版：预警等级：低
2021年01月发布的2020版：不在预警名单中
《国际期刊预警名单（试行）》2023版共计包含28本期刊（查看）
《国际期刊预警名单（试行）》2021版共计包含35本期刊（查看）
《国际期刊预警名单（试行）》2020版共计包含65本期刊（查看）
《Frontiers in Molecular Biosciences》相关链接
PubMed Central (PMC)链接：
http://www.ncbi.nlm.nih.gov/nlmcatalog?term=%5BISSN%5D
平均审稿速度：
14 Weeks
平均录用比例：
123学术网预审服务：
经过123学术网预审的论文，能够提前知晓自己的论文稿件是否达到自己目标分区、分值的杂志社的录用标准，同时节约自己大量投稿时间，若预审通过，123学术网客服会进一步向您反馈预审结果，如果双方对预审结果达成一致，则需要与我方签订咨询服务协议，以协助您结合审稿人的审稿意见进一步优化稿件质量，以实现文章录用结果。
若预审不能通过，说明论文稿件质量无法达到杂志社的录用标准，可考虑123学术网润色服务，不仅能满足Frontiers in Molecular Biosciences的语言要求，还能让Frontiers in Molecular Biosciences编辑和审稿人得到更好的审稿体验，让稿件最大限度被Frontiers in Molecular Biosciences编辑和审稿人充分理解和公正评估。
123学术网已助力全球10万+作者顺利发表论文。
《Frontiers in Molecular Biosciences》期刊简介
Much of contemporary investigation in the life sciences is devoted to the molecular-scale understanding of the relationships between genes and the environment — in particular, dynamic alterations in the levels, modifications, and interactions of cellular effectors, including proteins. Frontiers in Molecular Biosciences offers an international publication platform for basic as well as applied research; we encourage contributions spanning both established and emerging areas of biology. To this end, the journal draws from empirical disciplines such as structural biology, enzymology, biochemistry, and biophysics, capitalizing as well on the technological advancements that have enabled metabolomics and proteomics measurements in massively parallel throughput, and the development of robust and innovative computational biology strategies. We also recognize influences from medicine and technology, welcoming studies in molecular genetics, molecular diagnostics and therapeutics, and nanotechnology.
Our ultimate objective is the comprehensive illustration of the molecular mechanisms regulating proteins, nucleic acids, carbohydrates, lipids, and small metabolites in organisms across all branches of life.
In addition to interesting new findings, techniques, and applications, Frontiers in Molecular Biosciences will consider new testable hypotheses to inspire different perspectives and stimulate scientific dialogue. The integration of in silico, in vitro, and in vivo approaches will benefit endeavors across all domains of the life sciences.
